
### [MONDO:0018859](http://purl.obolibrary.org/obo/MONDO_0018859)
**Label:** Leigh disease

**Subclasses:** [MONDO:0014563](http://purl.obolibrary.org/obo/MONDO_0014563) (mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency), [MONDO:0013838](http://purl.obolibrary.org/obo/MONDO_0013838) (coenzyme Q10 deficiency, primary, 3), [MONDO:0011829](http://purl.obolibrary.org/obo/MONDO_0011829) (coenzyme Q10 deficiency, primary, 1), [MONDO:0009069](http://purl.obolibrary.org/obo/MONDO_0009069) (congenital lactic acidosis, Saguenay-Lac-saint-Jean type), [MONDO:0008069](http://purl.obolibrary.org/obo/MONDO_0008069) (necrotizing encephalomyelopathy, subacute, of Leigh, adult), [MONDO:0016816](http://purl.obolibrary.org/obo/MONDO_0016816) (Leigh syndrome with nephrotic syndrome), [MONDO:0016815](http://purl.obolibrary.org/obo/MONDO_0016815) (Leigh syndrome with leukodystrophy), [MONDO:0009723](http://purl.obolibrary.org/obo/MONDO_0009723) (Leigh syndrome), [MONDO:0019083](http://purl.obolibrary.org/obo/MONDO_0019083) (Leigh syndrome with cardiomyopathy), [MONDO:0016814](http://purl.obolibrary.org/obo/MONDO_0016814) (maternally-inherited Leigh syndrome), 

**Corr. equiv. classes:** [Orphanet:255241](http://www.orpha.net/ORDO/Orphanet_255241), [OMIM:614652](http://purl.obolibrary.org/obo/OMIM_614652), [Orphanet:255210](http://www.orpha.net/ORDO/Orphanet_255210), [OMIM:220111](http://purl.obolibrary.org/obo/OMIM_220111), [OMIM:607426](http://purl.obolibrary.org/obo/OMIM_607426), [Orphanet:70474](http://www.orpha.net/ORDO/Orphanet_70474), [Orphanet:255249](http://www.orpha.net/ORDO/Orphanet_255249), [OMIM:161700](http://purl.obolibrary.org/obo/OMIM_161700), [OMIM:616277](http://purl.obolibrary.org/obo/OMIM_616277), [OMIM:256000](http://purl.obolibrary.org/obo/OMIM_256000), [Orphanet:70472](http://www.orpha.net/ORDO/Orphanet_70472), 

**Class expressions from DL-Learner:**

- [HP:0001941](http://purl.obolibrary.org/obo/HP_0001941) (Acidosis) 29.41%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) 29.25%
- [HP:0004360](http://purl.obolibrary.org/obo/HP_0004360) (Abnormality of acid-base homeostasis) 29.09%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 28.52%
- Thing 28.52%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 28.52%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 24.88%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 24.84%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 24.72%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 24.25%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 24.21%
- [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 15.95%
- [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) 15.76%
- [HP:0000007](http://purl.obolibrary.org/obo/HP_0000007) (Autosomal recessive inheritance) 15.29%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 15.28%


